Teva Canada Product Recall (2018-11-23)
- Starting date:
- November 23, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-68408
Recalled Product
A. Novamoxin Granules for Oral Suspension 125mg/5mL
B. Novamoxin Granules for Oral Suspension 250mg/5mL
Reason
Out of specification results for homogeneity.
Depth of distribution
Retailers
Affected products
A. Novamoxin Granules for Oral Suspension 125mg/5mL
DIN, NPN, DIN-HIM
DIN 00452149
Dosage form
Granules for suspension
Strength
Amoxicillin 125mg/5mL
Lot or serial number
35438292B, 35438811A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. Novamoxin Granules for Oral Suspension 250mg/5mL
DIN, NPN, DIN-HIM
DIN 00452130
Dosage form
Granules for suspension
Strength
Amoxicillin 250mg/5mL
Lot or serial number
35439807A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA